Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
An announcement from Amplia Therapeutics ( (AU:ATX) ) is now available.
Amplia Therapeutics Limited has announced the issuance of 720,000 fully paid ordinary shares, which will be quoted on the Australian Securities Exchange (ASX) under the code ATX. This move is part of the company’s strategy to enhance its capital structure, potentially strengthening its market position and providing additional resources to support its ongoing research and development efforts.
More about Amplia Therapeutics
Amplia Therapeutics Limited operates in the biotechnology industry, focusing on the development of therapies for cancer and fibrotic diseases. The company is dedicated to advancing its pipeline of drug candidates to address unmet medical needs in these areas.
Average Trading Volume: 5,226,937
Technical Sentiment Signal: Buy
Current Market Cap: A$91.17M
See more data about ATX stock on TipRanks’ Stock Analysis page.